Abstract
Four patients with levodopa induced fluctuations in motor performance were studied during the constant intraduodenal infusion of levodopa. The results confirm that steady plasma levodopa levels with stable motor control can be achieved. However, when patients were given oral protein loads, motor performance declined despite maintenance of plasma levodopa levels. These findings suggest that competition for levodopa carrier mediated transport by amino acids, is more important at the blood-brain barrier than across the gut mucosa; thereby possibly limiting the efficacy of long-term direct intraduodenal administration of levodopa.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Eriksson T., Granérus A. K., Linde A., Carlsson A. 'On-off' phenomenon in Parkinson's disease: relationship between dopa and other large neutral amino acids in plasma. Neurology. 1988 Aug;38(8):1245–1248. doi: 10.1212/wnl.38.8.1245. [DOI] [PubMed] [Google Scholar]
- Evans M. A., Triggs E. J., Broe G. A., Saines N. Systemic activity of orally administered L-dopa in the elderly Parkinson patient. Eur J Clin Pharmacol. 1980;17(3):215–221. doi: 10.1007/BF00561903. [DOI] [PubMed] [Google Scholar]
- Fahn S. "On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine. Neurology. 1974 May;24(5):431–441. doi: 10.1212/wnl.24.5.431. [DOI] [PubMed] [Google Scholar]
- Farrant M., Zia-Gharib F., Webster R. A. Automated pre-column derivatization with o-phthalaldehyde for the determination of neurotransmitter amino acids using reversed-phase liquid chromatography. J Chromatogr. 1987 Jul 3;417(2):385–390. doi: 10.1016/0378-4347(87)80133-0. [DOI] [PubMed] [Google Scholar]
- Juncos J. L., Fabbrini G., Mouradian M. M., Serrati C., Chase T. N. Dietary influences on the antiparkinsonian response to levodopa. Arch Neurol. 1987 Oct;44(10):1003–1005. doi: 10.1001/archneur.1987.00520220009006. [DOI] [PubMed] [Google Scholar]
- Kurlan R., Rubin A. J., Miller C., Rivera-Calimlim L., Clarke A., Shoulson I. Duodenal delivery of levodopa for on-off fluctuations in parkinsonism: preliminary observations. Ann Neurol. 1986 Aug;20(2):262–265. doi: 10.1002/ana.410200213. [DOI] [PubMed] [Google Scholar]
- Leenders K. L., Poewe W. H., Palmer A. J., Brenton D. P., Frackowiak R. S. Inhibition of L-[18F]fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography. Ann Neurol. 1986 Aug;20(2):258–262. doi: 10.1002/ana.410200212. [DOI] [PubMed] [Google Scholar]
- Nutt J. G., Woodward W. R., Hammerstad J. P., Carter J. H., Anderson J. L. The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport. N Engl J Med. 1984 Feb 23;310(8):483–488. doi: 10.1056/NEJM198402233100802. [DOI] [PubMed] [Google Scholar]
- Pincus J. H., Barry K. M. Plasma levels of amino acids correlate with motor fluctuations in parkinsonism. Arch Neurol. 1987 Oct;44(10):1006–1009. doi: 10.1001/archneur.1987.00520220012007. [DOI] [PubMed] [Google Scholar]
- Wade D. N., Mearrick P. T., Birkett D. J., Morris J. Variability of L-dopa absorption in man. Aust N Z J Med. 1974 Apr;4(2):138–143. doi: 10.1111/j.1445-5994.1974.tb03162.x. [DOI] [PubMed] [Google Scholar]
- Wade D. N., Mearrick P. T., Morris J. L. Active transport of L-dopa in the intestine. Nature. 1973 Apr 13;242(5398):463–465. doi: 10.1038/242463a0. [DOI] [PubMed] [Google Scholar]
- Wade L. A., Katzman R. 3-O-methyldopa uptake and inhibition of L-dopa at the blood-brain barrier. Life Sci. 1975 Jul 1;17(1):131–136. doi: 10.1016/0024-3205(75)90248-9. [DOI] [PubMed] [Google Scholar]
- Wade L. A., Katzman R. Synthetic amino acids and the nature of L-DOPA transport at the blood-brain barrier. J Neurochem. 1975 Dec;25(6):837–842. doi: 10.1111/j.1471-4159.1975.tb04415.x. [DOI] [PubMed] [Google Scholar]